Nephrotic syndrome Notes


Osmosis High-Yield Notes

This Osmosis High-Yield Note provides an overview of Nephrotic syndrome essentials. All Osmosis Notes are clearly laid-out and contain striking images, tables, and diagrams to help visual learners understand complex topics quickly and efficiently. Find more information about Nephrotic syndrome:

Diabetic nephropathy

Focal segmental glomeruloscerosis (NORD)

Lupus nephritis

Membranoproliferative glomerulonephritis

Membranous nephropathy

Minimal change disease

NOTES NOTES NEPHROTIC SYNDROME GENERALLY, WHAT IS IT? PATHOLOGY & CAUSES ▪ Collection of diseases caused by inflammation, damage to glomeruli of kidney; glomeruli become more permeable, allow proteins from blood into urine → proteinuria Proteinuria ▪ Hallmark of nephrotic syndromes ▫ Loss of protein (mostly albumin) → hypoalbuminemia; lowers oncotic pressure in blood → water moves out of vessels into interstitium → edema ▫ ↓ proteins → ↑ lipids → hyperlipidemia; ↑ lipids filtered in glomeruli → lipiduria; fatty casts, foamy urine CAUSES ▪ Immune-mediated, metabolic, hemodynamic disturbances ▪ Primary: kidney lesion ▫ Minimal change disease, focal segmental glomerulosclerosis, membranous glomerulonephritis, membranoproliferative glomerulonephritis ▪ Secondary: systemic disease ▫ Diabetic nephropathy, lupus nephritis COMPLICATIONS ▪ Loss of proteins (e.g. anticoagulants, ironcarrying proteins): thromboembolism, renal vein thrombosis, microcytic hypochromic anemia, infections, hypocalcaemia SIGNS & SYMPTOMS ▪ Proteinuria, hypoalbuminemia, edema, hyperlipidemia, lipiduria, hypercoagulability DIAGNOSIS LAB RESULTS ▪ Protein/blood in urine ▪ Decreased glomerular filtration rate: estimated from serum creatinine clearance Kidney biopsy ▪ Changes under light/electron microscope, immunofluorescence ▪ Blood test: albumin, cholesterol levels TREATMENT MEDICATIONS ▪ Edema ▫ Diuretics (furosemide), medical nutrition therapy ▪ Blood pressure control ▫ Angiotensin converting enzyme (ACE) inhibitors ▪ Hyperlipidemia ▫ Reduce cholesterol, saturated fat intake ▪ Hypercoagulability ▫ Heparin ▪ Infections ▫ Antibacterial drugs ▪ Immunosuppressants ▫ Cyclophosphamide, prednisone MNEMONIC: Protein LEAC Nephrotic syndrome findings Proteinuria Lipid up Edema Albumin down Cholesterol up OSMOSIS.ORG 835
DIABETIC NEPHROPATHY PATHOLOGY & CAUSES ▪ Kidney damage caused by Type I, Type II diabetes CAUSES Excess glucose in blood ▪ Overrides renal threshold for glucose (160–180mg/dl) → glycosuria ▪ Non-enzymatic glycation of proteins → basement membranes thicken → hyaline arteriosclerosis ▪ Hyaline arteriosclerosis, arteriole dilatation increases pressure in glomerulus → increased glomerular filtration rate (first stage) ▪ Thickening of basement membrane → glomerulus expands, filtration slits widen → increased permeability ▪ High-pressure state → supportive mesangial cells secrete more structural matrix → Kimmelstiel–Wilson nodules ▪ Damage glomeruli → decreased glomerular filtration rate (second stage) Figure 118.1 Histological appearance of the glomeruli in a case of diabetic nephropathy. There is diffuse sclerosis of the glomerulus. 836 OSMOSIS.ORG RISK FACTORS ▪ Family history; poor control of diabetes, duration of diabetes (more common if developed at younger age); poor control of hypertension; obesity SIGNS & SYMPTOMS ▪ Mostly asymptomatic DIAGNOSIS LAB RESULTS ▪ Microalbuminuria (30–300mg/day), macroalbuminuria (> 300mg/day) TREATMENT MEDICATIONS ▪ Control hyperglycemia ▪ ACE inhibitors/angiotensin receptor blockers: reduce constriction of efferent arteriole → lower pressure in glomerulus
Chapter 118 Nephrotic Syndrome FOCAL SEGMENTAL GLOMERULOSCLEROSIS PATHOLOGY & CAUSES ▪ Histologic finding of glomerular damage, not distinct disease. ▪ Affects parts (segmental) of some (focal) glomeruli of nephron; damage, scarring → proteinuria ▪ Foot processes of podocytes damaged → plasma proteins, lipids permeate glomerular filter ▪ Proteins, lipids trapped → build up inside glomeruli → hyalinosis (hyaline/ glassy view on histology) → scar tissue (glomerulosclerosis) CAUSE ▪ Primary: unknown ▪ Secondary: result of underlying cause ▫ Sickle cell disease, HIV, renal hyperfiltration (e.g. unilateral renal agenesis), heroin abuse ▪ Genetic forms: FSGS 1–6 RISK FACTORS ▪ More common in black people of African descent/people of Latin American descent ▪ Morbid obesity ▪ Chronic kidney disease (congenital malformation) DIAGNOSIS LAB RESULTS ▪ Protein in urine > 3.5g/L Kidney biopsy: most definitive ▪ Light microscopy: segmental sclerosis, hyalinosis of glomeruli ▪ Electron microscope: effacement of foot processes of podocytes ▪ Immunofluorescence: nonspecific focal deposits of IgM, complement proteins not always seen (sometimes trapped in hyalinosis) TREATMENT MEDICATIONS ▪ Blood pressure reduction ▫ ACE inhibitors ▪ Edema ▫ Diuretics ▪ Prednisone/calcineurin inhibitors ▫ Depend on nephrotic-range proteinuria, likelihood of reversibility COMPLICATIONS ▪ End-stage renal failure: inconsistent response with treatment; adults—more involved segments of kidney’s glomeruli → kidney failure SIGNS & SYMPTOMS ▪ Proteinuria, hypoalbuminemia, edema, hyperlipidemia, lipiduria, hypercoagulability Figure 118.2 Histological appearance of focal segmental glomerulosclerosis. There is sclerosis and hyalinosis of only one part of the glomerulus, in this case the hilar part. The more distal part is normal. OSMOSIS.ORG 837
LUPUS NEPHRITIS PATHOLOGY & CAUSES ▪ Inflammation of kidney due to systemic lupus erythematosus. ▪ Focal (nephrons in one area)/diffuse (all nephrons in both kidneys) ▪ Caused by antinuclear antibodies (antidsDNA): bind to nuclear antigens, form antigen-antibody complexes ▪ Antigen-antibody complexes deposit in capillary walls, basement membrane, Bowman’s space → initiate inflammatory response → Type III hypersensitivity reaction DIAGNOSIS LAB RESULTS Kidney biopsy ▪ Microscopic presentation depends on class of lupus nephritis TYPES Class I ▪ Minimal mesangial glomerulonephritis Class II ▪ Mesangial proliferative glomerulonephritis Class III ▪ Focal glomerulonephritis Class IV ▪ Diffuse proliferative nephritis Class V ▪ Membranous glomerulonephritis Class VI ▪ Advanced sclerosing lupus nephritis COMPLICATIONS ▪ Renal vein thrombosis, pulmonary embolism, rapidly progressive glomerulonephritis SIGNS & SYMPTOMS ▪ Nephrotic, nephritic syndrome ▪ Nephritic syndrome: hematuria, hypertension, edema, proteinuria, oliguria 838 OSMOSIS.ORG Figure 118.3 Gross pathological appearance of a kidney in case of lupus nephritis. The renal capsule has a characteritic flea-bitten appearance.
Chapter 118 Nephrotic Syndrome TREATMENT MEDICATIONS ▪ Immunosuppressants ▫ Corticosteroids; mycophenolate, cyclophosphamide Figure 118.4 Histological appearance of the glomerulus in a case of lupus nephritis. There is global mesangial cell proliferation and abundant mesangial matrix. OSMOSIS.ORG 839
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS PATHOLOGY & CAUSES ▪ Type of nephrotic syndrome; inflammation of glomerular basement membrane, mesangium → decreased kidney function, proteinuria ▪ Immune complex/complement deposits trigger immune reactions ▫ Activates complement system → enzyme cascade → membrane attack complex → damage to podocytes, mesangial cells ▫ Recruits inflammatory cells → proteases, oxidants release → basement membrane damage → proteins leak into urine → nephrotic syndrome TYPES ▪ Appearance under light microscopy ▫ Type I, II, II ▫ All three can present as nephrotic, nephritic syndrome ▪ Immunofluorescence: immune complexmediated MPGN, complement-mediated MPGN CAUSES Type I ▪ Chronic infection (e.g. hepatitis B, hepatitis C) ▫ Antigens released → bind antibodies in blood → immune complexes deposit in glomerular basement membrane → activate classical complement pathway → complement protein + immune complex deposits ▪ Inappropriate activation of alternative pathway of complement ▫ Mutation in proteins that regulate pathway 840 OSMOSIS.ORG ▫ Presence of autoantibodies against proteins that regulate pathway ▪ Nephritic factor (C3NeF) ▫ IgG antibody, binds to C3 convertase → C3 convertase more stable, active longer ▫ Only complement deposits, no immune complex deposits ▫ Autoimmune diseases: systemic lupus erythematosus, scleroderma, Sjögren syndrome, sarcoidosis ▫ Cancer: leukemia, lymphoma Type II ▪ Nephritic factor (C3NeF) ▫ IgG antibody binds to C3 convertase → C3 convertase more stable, active longer Type III ▪ Idiopathic RISK FACTORS ▪ Dysregulation of complement system COMPLICATIONS ▪ Chronic renal failure, hypertension SIGNS & SYMPTOMS ▪ Nephrotic syndrome ▫ Proteinuria, peripheral edema, foamy urine, hyperlipidemia, lipiduria ▪ Nephritic syndrome (more common) ▫ Hematuria, oliguria (low production of urine), hypertension
Chapter 118 Nephrotic Syndrome DIAGNOSIS LAB RESULTS Kidney biopsy Electron microscopy ▪ Type I ▫ Subendothelial deposits ▫ Thickening of basement membrane ▫ Mesangial interposition: mesangial cells reach cytoplasmic arms through thick basement membrane, split lengthwise → duplicate basement membrane → “tram-track” appearance ▪ Type II ▫ Complement deposits along basement membrane of glomeruli, tubules, Bowman’s capsule ▪ Type III ▫ Subepithelial deposits in mesangium, subendothelial space TREATMENT MEDICATIONS ▪ Treatment of underlying cause (e.g. antiviral therapy for hepatitis B virus) ▪ If underlying cause ruled out/nephrotic range proteinuria ▫ Immunosuppressive therapy (steroids) MEMBRANOUS GLOMERULONEPHRITIS PATHOLOGY & CAUSES ▪ Inflammation of glomerular basement membrane triggered by immune complex deposits → increased permeability, proteinuria → nephrotic syndrome ▪ Glomerular basement membrane damaged by immune complex deposits; sandwiched between epithelial cells of podocytes, glomerular basement membrane (subendothelial deposits) ▪ Autoantibodies target glomerular basement membrane ▫ Two major antigen targets on podocytes: M-type phospholipase A2 receptor, neural endopeptidase ▪ Complexes outside kidney, carried through blood, deposit in basement membrane ▫ Possible antigens: cationic bovine serum albumin (cow’s milk, beef protein) ▪ Immune complex deposits → immune reactions ▫ Activates complement system → enzyme cascade → membrane attack complex → damage to podocytes, mesangial cells ▫ Recruits inflammatory cells → proteases, oxidants release → basement membrane damage → proteins leak into urine → nephrotic syndrome ▪ Often benign ▫ Spontaneous complete remission: 5–30% at five years ▫ Spontaneous partial remission: 25–40% at five years CAUSES Primary ▪ Mostly idiopathic ▪ Associated with human leukocyte antigen (HLA) alleles (e.g. HLA-DQA1) OSMOSIS.ORG 841
Secondary ▪ Auto-antibodies generated in response to underlying conditions ▪ Infections ▫ Hepatitis B virus, hepatitis C virus, syphilis ▪ Medications ▫ NSAIDs, penicillamine, gold ▪ Autoimmune ▫ Systemic lupus erythematosus ▪ Malignancy RISK FACTORS ▪ White people of European descent ▪ Increase risk of end-stage renal disease ▫ Older age at onset (> 50 years), individuals who are biologically male, nephrotic-range proteinuria (> 8–10g/ day), increased serum creatinine COMPLICATIONS ▪ Chronic kidney failure, if untreated + nephrotic range proteinuria SIGNS & SYMPTOMS ▪ Often asymptomatic, discovered incidentally ▪ Proteinuria, hypoalbuminemia, edema, hyperlipidemia, lipiduria, hypercoagulability; develop gradually over months DIAGNOSIS LAB RESULTS ▪ Proteinuria Renal biopsy ▪ Light microscopy ▫ Diffuse thickening of glomerular basement membrane ▪ Electron microscopy ▫ “Spike and dome” appearance due to glomerular basement matrix on top of subepithelial deposits; effacement of podocytes ▪ Immunofluorescence ▫ Deposits appear granular throughout glomerular basement membrane ▪ If kidney biopsy not an option ▫ Serum: assayed for antibodies associated with membranous glomerulonephritis (anti-PLA2R antibody) TREATMENT MEDICATIONS Primary cause ▪ Diuretics (furosemide), ACE inhibitors, heparin, antibacterial drugs ▫ Symptomatic therapy ▪ Close observation, no immunosuppression ▫ If at low risk of end-stage renal disorder (i.e. proteinuria < 3.5g/day) ▪ Prednisone + calcineurin inhibitor (e.g. tacrolimus, cyclosporine)/cytotoxic agent (e.g. cyclophosphamide) ▫ If at moderate/high risk of end-stage renal disorder ▪ Rituximab Secondary cause ▪ Treat underlying condition Figure 118.5 Histological appearance of membranous glomerulonephritis. The basement membrane of the glomerulus is markedly thickened. 842 OSMOSIS.ORG OTHER INTERVENTIONS ▪ Lifestyle changes ▫ Medical nutrition therapy, reduce cholesterol, saturated fat intake
Chapter 118 Nephrotic Syndrome MINIMAL CHANGE DISEASE PATHOLOGY & CAUSES ▪ Type of glomerulonephritis; podocytes in glomeruli damaged by T cells cytokines ▪ Foot processes of podocytes damaged, flattened (AKA effacement) → lose function as barrier → albumin permeates, bigger proteins cannot get through (selective proteinuria) CAUSES ▪ Unknown; T cells release cytokines, may cause effacement of podocytes RISK FACTORS ▪ Recent infection; immunization; immune stimulus; medications: nonsteroidal antiinflammatory drugs (NSAIDs) ▪ Hematologic malignancies (e.g. Hodgkin’s lymphoma) ▪ Most common nephrotic syndrome in children DIAGNOSIS LAB RESULTS ▪ Protein in urine > 3.5g/day Kidney biopsy ▪ Corticosteroid resistant patients ▪ Light microscopy ▫ Glomeruli appear normal, hence “minimal change disease” ▪ Electron microscopy ▫ Effacement of foot processes. ▪ Immunofluorescence ▫ Negative (no immune complex deposition) TREATMENT MEDICATIONS ▪ Prednisone therapy ▫ Excellent response, more quickly in children than adults; potential relapse COMPLICATIONS ▪ Relatively benign, does not affect kidney function SIGNS & SYMPTOMS ▪ Proteinuria, hypoalbuminemia, edema, hyperlipidemia, lipiduria, hypercoagulability ▪ Onset more rapid (days to weeks) than other nephrotic syndromes Figure 118.6 An illustration demonstrating the pathophysiology of minimal change disease. OSMOSIS.ORG 843

Osmosis High-Yield Notes

This Osmosis High-Yield Note provides an overview of Nephrotic syndrome essentials. All Osmosis Notes are clearly laid-out and contain striking images, tables, and diagrams to help visual learners understand complex topics quickly and efficiently. Find more information about Nephrotic syndrome by visiting the associated Learn Page.